Application Cycle
October 2024
This technology will use the bacterial hydrophilin DtpA to enhance the stability and viability of probiotics and enzymes under extreme conditions, improving strain diversity, bacterial recovery, and enzyme protection for microbiome-based therapeutics.
Awardee
Department